Ivy Brain Tumor Center and SonALAsense Announce Positive Initial Results
The Ivy Brain Tumor Center at Barrow Neurological Institute and SonALAsense announced positive results in their first-in-human Phase 0/1 clinical trial of SDT in recurrent glioblastoma patients. The